Compelling evidence has suggested that the hyperleptinemic condition (increased plasma leptin concentration) in obesity is one of important factors contributing to the hyper-activated SNS which eventually leads to many cardiovascular complications [3, 8–10]. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.